Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Net Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt net assets. Based on the latest financial reports, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) has net assets worth €1.30 Trillion EUR (≈ $1.52 Trillion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.60 Trillion ≈ $1.87 Trillion USD) and total liabilities (€298.87 Billion ≈ $349.42 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore RIG2 net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.30 Trillion |
| % of Total Assets | 81.33% |
| Annual Growth Rate | 8.08% |
| 5-Year Change | 51.77% |
| 10-Year Change | 105.45% |
| Growth Volatility | 5.16 |
Net Assets of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2025)
Net assets of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2025. This chart illustrates how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's net assets have evolved over time, based on quarterly financial data. See net asset quality index of Richter Gedeon Vegyészeti Gyár Nyilvános to measure how much of total assets are equity-financed.
Annual Net Assets for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2025)
The table below shows the annual net assets of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2025. For live market cap and overall valuation, see Richter Gedeon Vegyészeti Gyár Nyilvános stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €1.40 Trillion ≈ $1.64 Trillion |
+7.44% |
| 2024-12-31 | €1.30 Trillion ≈ $1.52 Trillion |
+14.12% |
| 2023-12-31 | €1.14 Trillion ≈ $1.34 Trillion |
+7.75% |
| 2022-12-31 | €1.06 Trillion ≈ $1.24 Trillion |
+14.88% |
| 2021-12-31 | €923.02 Billion ≈ $1.08 Trillion |
+13.40% |
| 2020-12-31 | €813.94 Billion ≈ $951.58 Billion |
+12.29% |
| 2019-12-31 | €724.87 Billion ≈ $847.45 Billion |
+5.71% |
| 2018-12-31 | €685.75 Billion ≈ $801.71 Billion |
+3.27% |
| 2017-12-31 | €664.02 Billion ≈ $776.31 Billion |
-2.62% |
| 2016-12-31 | €681.87 Billion ≈ $797.18 Billion |
+10.27% |
| 2015-12-31 | €618.39 Billion ≈ $722.96 Billion |
+10.09% |
| 2014-12-31 | €561.73 Billion ≈ $656.72 Billion |
+1.91% |
| 2013-12-31 | €551.20 Billion ≈ $644.41 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 171.8% over the analyzed period, indicating profitable operations and earnings retention.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Net Assets Breakdown (December 2025)
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €1.36 Trillion | 97.19% |
| Other Components | €39.33 Billion | 2.81% |
| Total Equity | €1.40 Trillion | 100.00% |
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors by Market Cap
The table below lists competitors of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bank of Maharashtra
NSE:MAHABANK
|
$6.57 Billion |
|
Turkiye Vakiflar Bankasi TAO
IS:VAKBN
|
$6.57 Billion |
|
PSP Swiss Property AG
SW:PSPN
|
$6.58 Billion |
|
Ampol Ltd
AU:ALD
|
$6.58 Billion |
|
CSPC Innovation Pharmaceutical Co Ltd Class A
SHE:300765
|
$6.56 Billion |
|
Coca-Cola FEMSA S.A.B. de C.V
MX:KOFUBL
|
$6.55 Billion |
|
Healthcare Realty Trust Incorporated
NYSE:HR
|
$6.55 Billion |
|
Informatica Inc
NYSE:INFA
|
$6.55 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,300,462,000,000 to 1,398,394,000,000, a change of 97,932,000,000 (7.5%).
- Net income of 232,335,000,000 contributed positively to equity growth.
- Dividend payments of 93,074,000,000 reduced retained earnings.
- Share repurchases of 1,988,000,000 reduced equity.
- Other factors decreased equity by 39,341,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €232.34 Billion | +16.61% |
| Dividends Paid | €93.07 Billion | -6.66% |
| Share Repurchases | €1.99 Billion | -0.14% |
| Other Changes | €-39.34 Billion | -2.81% |
| Total Change | €- | 7.53% |
Book Value vs Market Value Analysis
This analysis compares Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €3538.90 | €35.14 | x |
| 2018-12-31 | €3649.55 | €35.14 | x |
| 2019-12-31 | €3866.34 | €35.14 | x |
| 2020-12-31 | €4344.46 | €35.14 | x |
| 2021-12-31 | €4922.99 | €35.14 | x |
| 2022-12-31 | €5646.29 | €35.14 | x |
| 2023-12-31 | €6186.99 | €35.14 | x |
| 2024-12-31 | €7130.46 | €35.14 | x |
| 2025-12-31 | €7667.14 | €35.14 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.61%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 25.01%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 1.21x
- Recent ROE (16.61%) is above the historical average (10.46%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 7.80% | 12.15% | 0.49x | 1.30x | €-12.07 Billion |
| 2014 | 4.47% | 7.05% | 0.49x | 1.29x | €-30.91 Billion |
| 2015 | 8.75% | 14.75% | 0.49x | 1.21x | €-7.66 Billion |
| 2016 | 9.76% | 16.99% | 0.48x | 1.20x | €-1.60 Billion |
| 2017 | 1.35% | 2.00% | 0.58x | 1.15x | €-57.05 Billion |
| 2018 | 5.20% | 7.93% | 0.56x | 1.17x | €-32.67 Billion |
| 2019 | 6.56% | 9.28% | 0.59x | 1.20x | €-24.66 Billion |
| 2020 | 12.97% | 18.47% | 0.60x | 1.18x | €23.99 Billion |
| 2021 | 15.26% | 22.14% | 0.55x | 1.25x | €48.14 Billion |
| 2022 | 14.82% | 19.38% | 0.60x | 1.28x | €50.59 Billion |
| 2023 | 14.05% | 19.73% | 0.59x | 1.20x | €45.77 Billion |
| 2024 | 18.40% | 27.90% | 0.53x | 1.24x | €109.20 Billion |
| 2025 | 16.61% | 25.01% | 0.55x | 1.21x | €92.50 Billion |
Industry Comparison
This section compares Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,676,957,497
- Average return on equity (ROE) among peers: -45.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) | €1.30 Trillion | 7.80% | 0.23x | $6.56 Billion |
| SHANG.FOS.PHARM.GR.H YC 1 (08HH) | $61.84 Billion | 5.45% | 0.94x | $1.20 Billion |
| PEPTONIC MEDICAL (28L) | $75.32 Million | -56.54% | 0.42x | $5.52 Million |
| Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) | $5.95 Billion | 11.12% | 0.39x | $692.11 Million |
| WEST ISLAND BRANDS INC. (39N0) | $3.27 Million | -157.21% | 0.88x | $1.34 Million |
| HANSOH PHARMAC. HD-00001 (3KY) | $28.68 Billion | 15.24% | 0.10x | $22.06 Billion |
| AYURCANN HOLDINGS CORP. (3ZQ0) | $2.69 Million | -197.11% | 3.73x | $97.35K |
| CERENO SCIENTIFIC AB B (4A1) | $216.42 Million | -22.23% | 0.32x | $57.92 Million |
| MAPLE LEAF GREEN WORLD (4HV0) | $-8.51 Million | 0.00% | 0.00x | $504.30K |
| LORDS CO. WORLDW. HOLD. (4XM) | $-1.01 Million | 0.00% | 0.00x | $134.78K |
| RED LIGHT HOLLAND CORP. (4YX) | $11.22 Million | -54.38% | 0.30x | $6.62 Million |
About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more